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Dosing renally cleared drugs in critically ill children: 
mind the trap of glomerular hyperfiltration !
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• GHF is a common phenomenon in the pediatric ICU, especially in the 
youngest children and those not on vasopressor support. 
• We recommend using an age dependent definition of GHF, related to 
renal maturation processes.  
• As GHF may lead to subtherapeutic treatment of renally eliminated 
drugs, early detection of patients at risk is of main importance. 
This study was a single center, prospective, observational study,
conducted at the pediatric intensive care unit (PICU) and the cardiac
surgery intensive care unit (CSICU) of the Ghent University Hospital,
Belgium. Patients between 1 month and 15 years of age with a
bladder catheter were enrolled. GFR was measured by means of a
calculated 24 hours creatinine clearance (24h ClCr) during a
maximum of 4 consecutive days. GHF was defined as a GFR
exceeding normal values for age plus two standard deviations.
Logistic regression analysis was used to identify covariates for GHF.
The following variables with a clinical plausibility were entered in
univariate analysis: age, weight, length, body surface area (BSA),
amount of IV fluids administered, and vasopressor support. Those
with an a priori determined p value < 0.10 in univariate analysis
were entered in multivariate regression analysis
Glomerular hyperfiltration (GHF), defined as an elevated
glomerular filtration rate (GFR), induces the enhanced elimination
of circulating solute by the kidneys. Recently, this phenomenon
has received increasing attention in critically ill adults. The
incidence in this setting is high, varying between 28-65%. In
critically ill children, data on the incidence of GHF are scarce.
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Data were collected from 65 patients (median age 1.7 years, IQR 3.0). On the first day following admission to the ICU, 80% of patients expressed GHF. In total, GHF was seen at
least once in 84.6% of patients. Smaller BSA, strongly correlated to younger age, and the absence of vasopressor support were found as independent associated factors with
the development of GHF (table 1).
2. AIM
Primary objective: 
To investigate the incidence of GHF in critically ill children.  
Secondary objective: 
To identify factors associated with the development of GHF.
Fig 1. Age dependent normal GFR (pink) and
limit for GHF (blue)
Fig 2. Creatinine clearance in patients with vs. without GHF. 
GHF patients had a median 24 hours creatinine clearance of 181.8 ml/min/1.73m² (IQR 75.0) 
on the first day, compared to 40.2 ml/min/1.73m² (IQR 78.9) in patients without GHF.
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Fig 3. Evolution of GHF during the study. 
The percentage of patients presenting with GHF slowly decreases during consecutive days 
following admission to the ICU. 
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Table 1. Variables associated with GHF (logistic regression, multivariate analysis)
Smaller BSA and the absence of vasopressor support were independently associated with 
the development of GHF. OR = odds ratio, CI = confidence interval. 
Hosmer-Lemeshow (goodness-of-fit): χ² = 11.972, df = 8, P=0.152. 
Factor OR 95% CI P-value
BSA 0.078 0.019-0.319 < 0.001
Vasopressor support 0.258 0.097-0.687 0.007
